Massive study tracks Long-Term safety of new lupus drug

NCT ID NCT05141201

Ongoing Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

Summary

This study is collecting real-world information on the long-term safety and effectiveness of the drug Saphnelo (anifrolumab) for people with systemic lupus. It involves over 1,600 patients whose lupus hasn't responded well to other available treatments. The main goal is to monitor for side effects and see how well the drug works in everyday medical practice.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Research Site

Aichi, Japan
Research Site

Akita, Japan
Research Site

Aomori, Japan
Research Site

Chiba, Japan
Research Site

Ehime, Japan
Research Site

Fukui, Japan
Research Site

Fukuoka, Japan
Research Site

Fukushima, Japan
Research Site

Gifu, Japan
Research Site

Gunma, Japan
Research Site

Hiroshima, Japan
Research Site

Hokkaido, Japan
Research Site

Hyōgo, Japan
Research Site

Ibaraki, Japan
Research Site

Ishikawa, Japan
Research Site

Kagawa, Japan
Research Site

Kagoshima, Japan
Research Site

Kanagawa, Japan
Research Site

Kochi, Japan
Research Site

Kumamoto, Japan
Research Site

Kyoto, Japan
Research Site

Mie, Japan
Research Site

Miyagi, Japan
Research Site

Miyazaki, Japan
Research Site

Nagano, Japan
Research Site

Nagasaki, Japan
Research Site

Nara, Japan
Research Site

Niigata, Japan
Research Site

Numakunai, Japan
Research Site

Okayama, Japan
Research Site

Okinawa, Japan
Research Site

Osaka, Japan
Research Site

Ōita, Japan
Research Site

Saga, Japan
Research Site

Saitama, Japan
Research Site

Shiga, Japan
Research Site

Shimane, Japan
Research Site

Shizuoka, Japan
Research Site

Tochigi, Japan
Research Site

Tokushima, Japan
Research Site

Tokyo, Japan
Research Site

Tottori, Japan
Research Site

Toyama, Japan
Research Site

Wakayama, Japan
Research Site

Yamagata, Japan
Research Site

Yamaguchi, Japan
Research Site

Yamanashi, Japan

Conditions

Explore the condition pages connected to this study.

LUPUS ERYTHEMATOSUS, SYSTEMIC